HomeAI · summaries
Storia in 12 fonti
Trump floats countdown to 200% tariffs on generic drugs imported to US
While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. | While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. prescriptions—won’t stay in the clear for long.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
supplychaindive.com
Trump maps out 200% tariffs for generic pharmaceuticals
The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.
- ·
biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
